IFNG and neoplasm: An early release of IFNγ may be of relevance also for upregulating co-stimulatory molecules on dendritic cell (DC) surface, endowing DCs with a more potent triggering potential for tumor-specific CD8+ T cells (27), but also, as highlighted below, for the expression of ligands of immune inhibitory receptors.